From Target Engagement to Protein Degradation

Targeted Protein Degradation (TPD)

Targeted Protein Degradation (TPD) and other targeted protein degradation strategies offer a novel approach to eliminate disease-driving proteins that may be difficult to address through conventional inhibition. BioDuro integrates degrader design, degradation biology, DMPK, and translational expertise to help advance programs from concept through preclinical evaluation.

By combining chemistry, biology, DMPK, and bioanalytical expertise within one collaborative platform, our teams help reduce handoff challenges and accelerate decision-making throughout Targeted Protein Degradation development.

0
+
Active Targeted Protein Degradation programs
0
+
Cell Lines Across Diverse Targets
0
~
Typical HiBiT Cell Line Generation
Multi-Gram Scale
Targeted Protein Degradation Synthesis Capabilities

Integrated Targeted Protein Degradation Discovery from Design to Degradation

BioDuro combines chemistry, biology, and DMPK expertise within one collaborative platform to help advance targeted protein degradation programs from early degrader design through biological validation and translational evaluation.

Target Engagement & Ternary Complexes

Understand degrader activity earlier

Evaluate cell permeability, intracellular target engagement, and ternary complex formation using NanoBRET, TR-FRET, SPR, and complementary assay approaches.

Quantitative Degradation Biology

Quantitatively measure endogenous target degradation

Monitor degradation profiles using HiBiT, NanoLuc, AlphaLISA, JESS, flow cytometry, and kinetic degradation assays.

Integrated Discovery Expertise

Integrated chemistry, biology, and DMPK support

Cross-functional teams help accelerate degrader optimization from early discovery through translational evaluation.

Supporting Every Stage of the Degradation Pathway

Targeted Protein Degradation (TPD) development requires a coordinated understanding of target engagement, degradation biology, and downstream functional effects. Our scientists apply complementary chemistry, biology, and translational approaches to evaluate degrader performance from early mechanistic studies through functional validation.

Cell Permeability & Target Engagement

Evaluate intracellular binding, occupancy, and degrader permeability using NanoBRET, HTRF, SPR, and complementary assay platforms.

Ternary Complex Formation

Characterize interactions between the target protein, degrader, and E3 ligase through kinetic and endpoint assay approaches.

Target Ubiquitination

Assess whether degrader candidates successfully initiate ubiquitination and downstream degradation signaling.

Proteasome Recruitment

Confirm recruitment of degradation machinery using mechanistic assay approaches designed for targeted protein degradation studies.

Target Protein Degradation

Quantitatively monitor endogenous protein degradation using HiBiT, NanoLuc, JESS, Western blot, AlphaLISA, and flow cytometry workflows.

Functional & Translational Biology

Connect degradation activity to downstream biological outcomes including viability, pharmacology, pathway modulation, and phenotypic response.

Key Technologies for Targeted Protein Degradation Evaluation

BioDuro applies multiple orthogonal assay platforms to characterize target engagement, ternary complex formation, and target degradation throughout PROTAC discovery programs.

HiBiT-Based Target Degradation Analysis

Customized HiBiT cell lines enable sensitive, real-time measurement of endogenous target degradation in living cells. Kinetic degradation studies provide quantitative insights into degrader performance and mechanism.

Key outputs include:

  • Dmax (maximum degradation)
  • DC50 (degradation potency)
  • Degradation rate
  • Time at Dmax
  • Protein recovery
Protact diagram 1
Figure 1: HiBiT assay principle and real-time comparison of target degradation versus target inhibition.

 

Protact diagram 2
Figure 2: Representative degradation kinetics, degradation rate analysis, and Dmax/DC50 determination across multiple PROTAC concentrations.

Ready to Advance Your Targeted Protein Degradation Discovery Program?

From degrader design and target engagement studies to quantitative degradation analysis and translational biology, BioDuro provides the scientific expertise and platform capabilities needed to help accelerate targeted protein degradation programs.

Whether you’re evaluating a new target, optimizing a degrader series, or advancing candidates toward preclinical development, our teams can support every stage of the discovery process.